Mr. Karsten Havkrog Pedersen was Independent Member of the Board of Directors of Genmab A/S since 2002. He also serves as Member of the Company Audit and Nominating & Corporationrationrate Governance Committees. Mr. Havkrog Pedersen is Partner at Bruun & Hjejle. He has over 25 years experience as an attorney within Danish corporate law and corporate governance. He was admitted as barrister to the Supreme Court of Justice in 1983. He also served as Member of the Danish Appeal Board and Member of the Danish Bar and Law Society, Committee of Legal Affairs . From 1991 to 2004, he was Member of the Editorial Committee of the Danish legal magazine Lov & Ret. Mr. Pedersen is Chairman of the Board of Directors of Redaktoer Hans Voigts Mindelegat and Member of the Board of EKJ Fonden.
The company has return on total asset (ROA) of (7.89) % which means that it has lost $7.89 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (25.16) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.74 M in total debt with debt to equity ratio (D/E) of 0.02 which may suggest the company is not taking enough advantage from borrowing. Genmab A-S has Current Ratio of 1.48 which is within standard range for the sector.
Genmab A/S, a biotechnology company, engages in the development of human antibody therapeutics for the potential treatment of cancer. Genmab A-S [GNMSF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
OTC Genmab A-S
0.78% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Copenhagen
